NCT07356180Enrolling by invitation
Physical Acvitiy in Pregnancy
Epigenetic Regulation of Physically Active Lifestyle on Placental Development
Source: ClinicalTrials.gov · Last updated 21 Jan 2026
Brief summary (registry, in English)
The goal of this observational study is to learn how a physically active lifestyle during pregnancy affects placental development and function. The main question it aims to answer is: Does regular physical activity during pregnancy improve placental function and support healthy fetal growth? Pregnant participants will provide biological samples and health information during pregnancy and at delivery. The study will use these samples to examine how activity levels relate to placental energy production and overall health.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 40 (estimated)
- First submitted
- 12 Jan 2026
- Start date
- 18 Oct 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Maryland, Baltimore
- Diseases
- Obesity
- NCT number
- NCT07356180
What you commit to
- Study type: Observational
- Planned participants: 40
- From 18 Oct 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Pre-existing diabetes or diagnosed with diabetes prior to 24weeks
Other illness
- Known severe fetal anomalies or genetic disorder
- Known infectious disease (ex: HIV, HepC)
Other
- Women \<18yo or \>45yo
- Non-English speaking
- Required complex diets/supplements not related to the pregnancy (i.e. malnutrition)
- Placenta accreta spectrum
- Emergent cesarean delivery performed due to fetal distress
Who the study is looking for
- Pregnant female and their newborn infant(s)
- Aged 18-45 (pregnant female), age 0-60 days of life (newborn infant)
- English speaking
- Screened for gestational diabetes with standard glucose tolerance test between 24w - 41w gestation
- Delivered at gestational age 34week-41weeks
- Delivered via non-emergent Cesarean section during weekday hours
- No known infectious disease (ex: HIV, HepC)
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Maryland Medical System Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.